logo

Cormedix Inc. (CRMD)



Trade CRMD now with
  Date
  Headline
8/5/2016 8:07:11 AM CorMedix Q2 Net Loss Flat At $4.88 Mln Or $0.13/shr
8/5/2016 8:06:55 AM CorMedix Q2 Loss Per Share Flat At $0.13
10/7/2015 6:03:18 AM Pacific Premier Bancorp Appoints Cora Tellez As An Independent Director
7/25/2015 9:34:47 PM Ryan & Maniskas LLP Announces Class Action Lawsuit Against CorMedix
6/17/2015 8:55:05 AM CorMedix Obtains Positive Feedback From FDA For Neutrolin Clinical Trial Protocol For Oncology Patients
3/4/2015 8:18:49 AM CorMedix Engages Evercore As Financial Advisor To Explore Strategic Alternatives To Maximize Shareholder Value
1/29/2015 9:06:42 AM FDA Grants QIDP Designation To Neutrolin, CorMedix's Lead Product Candidate In The U.S.
12/23/2014 8:31:14 AM CorMedix Finalizes First Middle East Neutrolin Sales/Distribution Agreement In Kingdom Of Saudi Arabia
12/4/2014 9:24:25 AM CorMedix Files Request With FDA For QIDP Designation For Neutrolin
10/27/2014 8:56:39 AM CorMedix Gets Approval From FDA To Initiate Clinical Trial For Neutrolin In US
9/25/2014 8:05:24 AM CorMedix Announces IND Filing For Neutrolin To FDA
9/22/2014 8:04:06 AM CorMedix Says Neutrolin Label Expansion Approved For European Union